IHB OpenIR  > 水生生物分子与细胞生物学研究中心  > 期刊论文
Proteomic analysis of multiple myeloma: Current status and future perspectives
Ge, Feng; Bi, Li-Jun; Tao, Sheng-Ce; Xu, Xu-dong; Zhang, Zhi-Ping; Kitazato, Kaio; Zhang, Xian-En; Ge, F, Wuhan Univ, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China; gefeng@ihb.ac.cn, x.zhang@wh.iov.cn
2011
Source PublicationPROTEOMICS CLINICAL APPLICATIONS
ISSN1862-8346
Volume5Issue:40545Pages:30-37
AbstractMultiple myeloma (MM) is a malignant plasma cell neoplasm that accounts for slightly more than 10% of all hematologic cancers and remains incurable. The major challenge remains the identification of better diagnosis and prognostic biomarkers. The advent of proteomic technologies creates new opportunities and challenges for those seeking to gain greater understanding of MM. Although there is a limited number of proteomic studies to date in MM, those performed highlight the potential impact of these technologies in our understanding of MM pathogenesis and the identification of novel therapeutic targets. In this review, we introduce the proteomic technologies available for the study of MM, summarize results of the published proteomic studies on MM, and discuss the novel developments and applications for the analysis of protein PTM in MM. The application of proteomic technologies will be valuable to better understand the pathogenesis of MM and may in the future open novel avenues in the treatment of MM.
KeywordBiomarkers Ms Multiple Myeloma Proteomics Ptm
Department[Ge, Feng; Xu, Xu-dong] Wuhan Univ, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China; [Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Tao, Sheng-Ce] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Zhang, Zhi-Ping; Zhang, Xian-En] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China; [Kitazato, Kaio] Nagasaki Univ, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan
Subject AreaBiochemical Research Methods ; Biochemistry & Molecular Biology
Funding OrganizationChinese Academy of Sciences ; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005, 2009ZX10004-107]; Slate Key Development Program for Basic Research of China [2010CB529205]; Program for New Century Excellent Talents in University [NCET-09-551] ; Chinese Academy of Sciences ; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005, 2009ZX10004-107]; Slate Key Development Program for Basic Research of China [2010CB529205]; Program for New Century Excellent Talents in University [NCET-09-551] ; Chinese Academy of Sciences ; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005, 2009ZX10004-107]; Slate Key Development Program for Basic Research of China [2010CB529205]; Program for New Century Excellent Talents in University [NCET-09-551] ; Chinese Academy of Sciences ; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005, 2009ZX10004-107]; Slate Key Development Program for Basic Research of China [2010CB529205]; Program for New Century Excellent Talents in University [NCET-09-551]
Indexed BySCI
Language英语
Funding OrganizationChinese Academy of Sciences ; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005, 2009ZX10004-107]; Slate Key Development Program for Basic Research of China [2010CB529205]; Program for New Century Excellent Talents in University [NCET-09-551] ; Chinese Academy of Sciences ; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005, 2009ZX10004-107]; Slate Key Development Program for Basic Research of China [2010CB529205]; Program for New Century Excellent Talents in University [NCET-09-551] ; Chinese Academy of Sciences ; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005, 2009ZX10004-107]; Slate Key Development Program for Basic Research of China [2010CB529205]; Program for New Century Excellent Talents in University [NCET-09-551] ; Chinese Academy of Sciences ; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005, 2009ZX10004-107]; Slate Key Development Program for Basic Research of China [2010CB529205]; Program for New Century Excellent Talents in University [NCET-09-551]
Document Type期刊论文
Identifierhttp://ir.ihb.ac.cn/handle/342005/15516
Collection水生生物分子与细胞生物学研究中心_期刊论文
Corresponding AuthorGe, F, Wuhan Univ, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China; gefeng@ihb.ac.cn, x.zhang@wh.iov.cn
Recommended Citation
GB/T 7714
Ge, Feng,Bi, Li-Jun,Tao, Sheng-Ce,et al. Proteomic analysis of multiple myeloma: Current status and future perspectives[J]. PROTEOMICS CLINICAL APPLICATIONS,2011,5(40545):30-37.
APA Ge, Feng.,Bi, Li-Jun.,Tao, Sheng-Ce.,Xu, Xu-dong.,Zhang, Zhi-Ping.,...&gefeng@ihb.ac.cn, x.zhang@wh.iov.cn.(2011).Proteomic analysis of multiple myeloma: Current status and future perspectives.PROTEOMICS CLINICAL APPLICATIONS,5(40545),30-37.
MLA Ge, Feng,et al."Proteomic analysis of multiple myeloma: Current status and future perspectives".PROTEOMICS CLINICAL APPLICATIONS 5.40545(2011):30-37.
Files in This Item: Download All
File Name/Size DocType Version Access License
Proteomic analysis o(133KB) 开放获取--View Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Ge, Feng]'s Articles
[Bi, Li-Jun]'s Articles
[Tao, Sheng-Ce]'s Articles
Baidu academic
Similar articles in Baidu academic
[Ge, Feng]'s Articles
[Bi, Li-Jun]'s Articles
[Tao, Sheng-Ce]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Ge, Feng]'s Articles
[Bi, Li-Jun]'s Articles
[Tao, Sheng-Ce]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: Proteomic analysis of multiple myeloma.pdf
Format: Adobe PDF
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.